Filing Flows › Capricor Therapeutics (CAPR) › Next earnings date
Capricor Therapeutics (CAPR) earnings on Nov 10, 2026: what to expect
Capricor Therapeutics (CAPR) is expected to report earnings on Nov 10, 2026, in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.41 (−$0.74 to $0.87, 8 estimates) on revenue of $10.4M, against −$0.54 a year ago. It beat the EPS estimate in 33% of the quarters on record; Filing Flows' model gives it a 59% chance of beating next time.
What to watch
Last quarter (Q4 2024) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.54, against the analysts' −$0.41.
The last report
Capricor Therapeutics reported revenue of $11.1M for the fourth quarter 2024 (-8% Y/Y), net loss $7.1M. How it makes money → · Every quarter →
Capricor Therapeutics' latest quarter
Capricor Therapeutics, Q4 2024: revenue $11.1M (-8% year over year), operating margin -69.1%, net loss $7.1M, operating cash flow −$14.8M. The chart follows the revenue to costs, profit and cash.
Questions
When does CAPR report earnings?
Capricor Therapeutics is expected to report on Nov 10, 2026.
What are analysts expecting from Capricor Therapeutics?
EPS of −$0.41 and revenue of $10.4M for the quarter.
Does Capricor Therapeutics usually beat earnings?
It beat the consensus EPS estimate in 33% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.